1
|
Singh N, Patel G, Dogra Y, Mohanty S, Seth T. P-795 Comparison of intra-ovarian platelet rich plasma versus autologous bone marrow derived stem cell instillation in women with diminished ovarian reserve for ovarian rejuvenation. Hum Reprod 2022. [PMCID: PMC9384354 DOI: 10.1093/humrep/deac107.731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
To compare role of intra-ovarian platelet rich plasma (PRP) versus marrow derived stem cell (SC) instillation for improvement in ovarian reserve (AFC, AMH and FSH)
Summary answer
Both PRP and SC therapy improves the ovarian reserve however, response to PRP is superior to SC post intervention
What is known already
With increasing incidence of females with diminished ovarian reserve (DOR), posing a serious challenge in terms of limited treatment options for these couples. Clinicians are trying to find effective strategies besides oocyte donation or adoption Of late, novel ovarian rejuvenation approaches has been investigated which are currently available for research purposes only. Multiple studies are evaluating effect of intra-ovarian PRP or autologous SC instillation, the results are encouraging as they are showing improvement in ovarian reserve thus bringing a paradigm shift in treatment options. None of the published studies so far have compared PRP versus SC in DOR population.
Study design, size, duration
A prospective comparative study was conducted at Division of Reproductive Medicine of a tertiary care institute. 72 infertile females (20-39 years) with poor ovarian reserve (AMH <1.2 ng /ml; AFC<5) were enrolled in the study between January 2020 to December 2021. The two comparative groups underwent either intra-ovarian PRP instillation (n = 42) or autologous SC transplantation (n = 30).
Participants/materials, setting, methods
After the two groups were matched (PRP vs SC) for baseline characteristics (Age, AMH, AFC, FSH, Estradiol), 30 subjects in each group were compared for change in serum FSH/AMH/Estradiol levels, AFC, right and left ovarian volume at 1st month and 3rd month post intervention from the baseline. This was also compared between the two groups using Student t-test. The cost and procedural pain measured using Visual analog scale (VAS) were also compared between the groups.
Main results and the role of chance
After matching for baseline characteristics, significant ∼ 1.8/2 and ∼1.5/1.6 fold increase in AFC at 1st/3rd month post intervention (p<0.001) was observed after PRP instillation and SC transplantation respectively. This significant improvement was observed more in PRP group than SC group at 3rd month post intervention (7.07 vs 5.60, p=0.02), while no significant difference existed at 1st month of follow up. However, there was no significant improvement in serum FSH, AMH and Estradiol levels (p0.05) from the baseline at 1st and 3rd month post intervention in both the groups. Similarly, there was no significant difference between the two groups in serum FSH level (7.98 IU/ml vs 9.62 IU/ml, p=0.062; 8.26 IU/ml vs 9.50 IU/ml, p=0.15), AMH level (1.62 ng/ml vs 1.02 ng/ml, p=0.27; 1.35 ng/ml vs 0.95 ng/ml, p=0.24), Estradiol level (49.12 pg/ml vs 56.48 pg/ml p=0.443; 54.7 pg/ml vs 61.12 pg/ml, p=0.44), right ovarian volume (3.13 cm3 vs 2.49 cm3, p=0.06; 3.37 cm3 vs 2.74 cm3,p=0.063) and left ovarian volume (2.98 cm3 vs 2.47 cm3, p=0.102; 2.87 cm3 vs 2.34 cm3,p=0.103) at 1st and 3rd month post intervention respectively. PRP was more cost-effective and associated with less pain (32.5 mm vs 28.13 mm, p=0.02), and better patient compliance.
Limitations, reasons for caution
This was a comparative study and the participants were not randomized but were matched for the baseline characteristics. Also due to impact of Covid-19 causing intermittent pause in nonessential facilities like IVF services, a smaller sample size could be enrolled and also clinical outcomes could not be evaluated
Wider implications of the findings
This study, although comparative, for the first time highlights the beneficial role of PRP over SC, thus can establish superiority of PRP as minimally invasive, economical, patient friendly and a recommended therapy for ovarian rejuvenation and folliculogenesis, providing the DOR females an opportunity to produce their own offspring.
Trial registration number
CTRI/2020/01/022726
Collapse
Affiliation(s)
- N Singh
- All India Institute Of Medical Sciences AIIMS, Department of Obstetrics & Gynaecology , New Delhi, India
| | - G Patel
- All India Institute Of Medical Sciences AIIMS, Department of Obstetrics & Gynaecology , New Delhi, India
| | - Y Dogra
- Indira Gandhi Institute of Medical Sciences, Reproductive Medicine , Shimla, India
| | - S Mohanty
- All India Institute Of Medical Sciences AIIMS, National Stem Cell Facility , New Delhi, India
| | - T Seth
- All India Institute Of Medical Sciences AIIMS, Department of Haematology , New Delhi, India
| |
Collapse
|
2
|
Tiwari S, Dass J, Vishwanathan G, Dhawan R, Agarwal M, Kumar P, Seth T, Tyagi S, Mahapatra M. P693: DIAGNOSTIC ROLE OF CD26+ LEUKEMIC STEM CELLS IN CHRONIC MYELOID LEUKEMIA. Hemasphere 2022. [DOI: 10.1097/01.hs9.0000845656.78528.24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
3
|
Singh N, Dogra Y, Mohanty S, Seth T. P–796 Trial of Autologous Marrow derived Stem Cell Ovarian Transplantation (TAMSCOT) in young infertile women with diminished ovarian reserve for ovarian rejuvenation – HOPE still persists. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Study question
Does autologous bone marrow derived stem cell (BMDSC) ovarian transplantation optimize ovarian reserve parameters in young infertile women with diminished ovarian reserve (DOR) ?
Summary answer
The autologous stem cell ovarian transplantation (ASCOT) improves AFC and AMH by facilitating the recruitment of existing dormant follicles in young women with DOR.
What is known already
Oocyte donation is the practical therapeutic option when patients with premature ovarian ageing desire pregnancy. It involves significant psychological burden in terms of not able to have their own biological child. ASCOT has opened new doors in poor responders and premature ovarian insufficiency through its beneficial effects on ovarian reserve and IVF outcomes. However recent studies have shown contradictory results in terms of its efficacy. No prior study has been contemplated in DOR group
Study design, size, duration
An open label non randomized controlled trial was conducted at Division of Reproductive Medicine in collaboration with stem cell facility at tertiary care institute. Forty two infertile women less than 35 years age with DOR (AFC<5, AMH<1.2ng/ml and /or high FSH>8IU/l) were enrolled in the study during a period from January 2020 to December 2020. 20 women who did not opt for the intervention were treated as control group whereas 22 women received the intervention.
Participants/materials, setting, methods
Baseline hormonal profile ( Day 2 FSH, estradiol, AMH and AFC) was done in all patients. Women with abnormal uterine cavity, endometriosis, prior ovarian surgery, abnormal karyotype were excluded. Bone marrow aspiration followed by mesenchymal stem cells isolation was performed. The stem cells were transplanted in both the ovaries through transvaginal route on the same day. Follow up visits were planned at one and six months to assess ovarian reserve parameters.
Main results and the role of chance
The mean age, BMI and duration of infertility were comparable between the control and study group (29.5±3.34vs29.36±2.95years, 21.51±1.40vs21.87±1.93kg/m2, 6.9±1.94vs7. 04±3.67 years) . The positive response in terms of improved AMH and AFC was seen in 68% (15/22) patients. The mean number of stem cells injected in these women were 77.71±25.33 million. At first follow up, there was no significant difference between mean FSH, estradiol levels and mean right and left ovarian volume (9.23±3.95 vs 9.02±3.92mIU/l, 61.46±29.25 vs 68.12±62.52 pg/ml, 2.82±2.18 vs 2.44±1.25 cc, 2.02±1.54 vs 2.72±1.06 cc, p < 0.05). There was significant increase in AMH and AFC values as compared to baseline (0.79±0.43 vs 1.26±0.82ng/ml, p = 0.03; 3.47±1.30 vs 6.40±2.23, p < 0.001). At second follow up visit, the significant increase in ovarian reserve persisted for AMH and AFC (0.79±0.43 vs 1.22±0.76 ng/ml, p = 0.02; 3.47±1.30 vs 6.93±1.71,p<0.001). There was no significant difference between serum FSH , Estradiol and ovarian volume. None of the patients developed any complication and the improvement in AFC and AMH persisted during 10 month follow up period.
Limitations, reasons for caution
The limitation of present study is small sample size and non randomization. However, time period for which positive effect lasts has not been documented in earlier studies. This study is currently being endeavored, and women with improved ovarian reserve are followed up for any spontaneous conception or following assisted reproduction.
Wider implications of the findings: The present study demonstrates beneficial role of stem cells in improving ovarian reserve parameters in women with DOR with no acquired cause. If supported by future randomized clinical studies, it could represent a paradigm shift for fertility treatment in these women providing an opportunity to have their own biological child.
Trial registration number
CTRI/2020/01/022726
Collapse
Affiliation(s)
- N Singh
- All India Institute Of Medical Sciences AIIMS, Department of Obstetrics & Gynaecology, New Delhi, India
| | - Y Dogra
- All India Institute Of Medical Sciences AIIMS, Department of Obstetrics & Gynaecology, New Delhi, India
| | - S Mohanty
- All India Institute Of Medical Sciences AIIMS, Stem cell facility, New Delhi, India
| | - T Seth
- All India Institute Of Medical Sciences AIIMS, Department of Haematology, New Delhi, India
| |
Collapse
|
4
|
Singh N, Dogra Y, Mohanty S, Seth T. P-796 Trial of Autologous Marrow derived Stem Cell Ovarian Transplantation (TAMSCOT) in young infertile women with diminished ovarian reserve for ovarian rejuvenation – HOPE still persists. Hum Reprod 2021. [DOI: 10.1093/humrep/deab128.037] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
Does autologous bone marrow derived stem cell (BMDSC) ovarian transplantation optimize ovarian reserve parameters in young infertile women with diminished ovarian reserve (DOR) ?
Summary answer
The autologous stem cell ovarian transplantation (ASCOT) improves AFC and AMH by facilitating the recruitment of existing dormant follicles in young women with DOR.
What is known already
Oocyte donation is the practical therapeutic option when patients with premature ovarian ageing desire pregnancy. It involves significant psychological burden in terms of not able to have their own biological child. ASCOT has opened new doors in poor responders and premature ovarian insufficiency through its beneficial effects on ovarian reserve and IVF outcomes. However recent studies have shown contradictory results in terms of its efficacy. No prior study has been contemplated in DOR group
Study design, size, duration
An open label non randomized controlled trial was conducted at Division of Reproductive Medicine in collaboration with stem cell facility at tertiary care institute. Forty two infertile women less than 35 years age with DOR (AFC<5, AMH<1.2ng/ml and /or high FSH>8IU/l) were enrolled in the study during a period from January 2020 to December 2020. 20 women who did not opt for the intervention were treated as control group whereas 22 women received the intervention.
Participants/materials, setting, methods
Baseline hormonal profile ( Day 2 FSH, estradiol, AMH and AFC) was done in all patients. Women with abnormal uterine cavity, endometriosis, prior ovarian surgery, abnormal karyotype were excluded. Bone marrow aspiration followed by mesenchymal stem cells isolation was performed. The stem cells were transplanted in both the ovaries through transvaginal route on the same day. Follow up visits were planned at one and six months to assess ovarian reserve parameters.
Main results and the role of chance
The mean age, BMI and duration of infertility were comparable between the control and study group (29.5±3.34vs 29.36±2.95years, 21.51±1.40vs21.87±1.93kg/m2, 6.9±1.94vs7.04±3.67 years). The positive response in terms of improved AMH and AFC was seen in 68% (15/22) patients. The mean number of stem cells injected in these women were 77.71±25.33 million. At first follow up, there was no significant difference between mean FSH, estradiol levels and mean right and left ovarian volume (9.23±3.95 vs 9.02±3.92mIU/l, 61.46±29.25 vs 68.12±62.52 pg/ml, 2.82±2.18 vs 2.44±1.25 cc, 2.02±1.54 vs 2.72±1.06 cc, p < 0.05). There was significant increase in AMH and AFC values as compared to baseline (0.79±0.43 vs 1.26±0.82ng/ml, p = 0.03; 3.47±1.30 vs 6.40±2.23, p < 0.001). At second follow up visit, the significant increase in ovarian reserve persisted for AMH and AFC (0.79±0.43 vs 1.22±0.76 ng/ml, p = 0.02; 3.47±1.30 vs 6.93±1.71,p<0.001). There was no significant difference between serum FSH, Estradiol and ovarian volume. None of the patients developed any complication and the improvement in AFC and AMH persisted during 10 month follow up period.
Limitations, reasons for caution
The limitation of present study is small sample size and non randomization. However, time period for which positive effect lasts has not been documented in earlier studies. This study is currently being endeavored, and women with improved ovarian reserve are followed up for any spontaneous conception or following assisted reproduction.
Wider implications of the findings
The present study demonstrates beneficial role of stem cells in improving ovarian reserve parameters in women with DOR with no acquired cause. If supported by future randomized clinical studies, it could represent a paradigm shift for fertility treatment in these women providing an opportunity to have their own biological child
Trial registration number
CTRI/2020/01/022726
Collapse
Affiliation(s)
- N Singh
- All India Institute Of Medical Sciences AIIMS, Department of Obstetrics & Gynaecology, New Delhi, India
| | - Y Dogra
- All India Institute Of Medical Sciences AIIMS, Department of Obstetrics & Gynaecology, New Delhi, India
| | - S Mohanty
- All India Institute Of Medical Sciences AIIMS, Stem cell facility, New Delhi, India
| | - T Seth
- All India Institute Of Medical Sciences AIIMS, Department of Haematology, New Delhi, India
| |
Collapse
|
5
|
Bhasym A, Annarapu GK, Saha S, Shrimali N, Gupta S, Seth T, Guchhait P. Neutrophils develop rapid proinflammatory response after engulfing Hb-activated platelets under intravascular hemolysis. Clin Exp Immunol 2019; 197:131-140. [PMID: 31099890 DOI: 10.1111/cei.13310] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/26/2019] [Indexed: 01/04/2023] Open
Abstract
Neutrophils maintain immune homeostasis by engulfing apoptotic cells and debris. We describe the rapid activation of neutrophils after engulfing hemoglobin (Hb)-activated platelets, which are abundant in the circulation of hemolytic patients. Neutrophils from healthy individuals after engulfing Hb-activated platelets express elevated CD11b and secrete significant amounts of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, myeloperoxidase (MPO) and elastase within 4-h platelets, but not with free-Hb only in vitro. These neutrophils exhibit early onset of apoptosis and cell death after engulfing Hb-activated platelets, but not with free-Hb only. Further, our data from mice with phenylhydrazine-induced intravascular hemolysis display a gradual decrease in total neutrophil count, but the number of activated neutrophils and neutrophil-platelet aggregates increases, along with the rise of TNF-α, IL-1β, IL-6 and MPO in circulation. Our data from paroxysmal nocturnal hemoglobinuria (PNH) patients confirmed the observation of decreased total neutrophil counts, but elevated numbers of activated neutrophils, including neutrophil-platelet aggregates, in parallel with elevated expression of TNFA, IL1B and IL6 genes in neutrophils, also increased levels of these cytokines along with MPO in circulation, and this correlated directly with elevated intravascular hemolysis (high free-Hb in plasma). The patients' neutrophils displayed significant localization of intracellular Hb and platelets, unlike the counterparts from healthy individuals. Together, therefore, our observations suggest that Hb-activated platelets, which are abundant in the circulation of patients with hemolytic disorders, including PNH, promotes early onset of neutrophil activation and increases their proinflammatory response and leads to early apoptosis and cell death.
Collapse
Affiliation(s)
- A Bhasym
- Disease Biology Laboratory, Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India.,Department of Biotechnology, Manipal Academy of Higher Education, Karnataka, India
| | - G K Annarapu
- Disease Biology Laboratory, Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India
| | - S Saha
- Disease Biology Laboratory, Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India
| | - N Shrimali
- Disease Biology Laboratory, Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India
| | - S Gupta
- Disease Biology Laboratory, Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India
| | - T Seth
- Hematology, Department of Medicine, All India Institute of Medical Sciences, New Delhi, India
| | - P Guchhait
- Disease Biology Laboratory, Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India
| |
Collapse
|
6
|
Kumar R, Gupta N, Seth T, Sharma A. PO-451 Novel combination of tanshinone I and dexamethasone induces apoptosis in myeloma cells by modulating ERK/p38/JNK/NF-kB signalling pathway. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.472] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
7
|
Gupta N, Kumar R, Khan R, Seth T, Garg B, Sharma A. PO-284 Involvement of versican, a chondroitin sulfate proteolgycan in the pathogenesis of multiple myeloma. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
8
|
Gupta A, Mishra P, Pati HP, Tyagi S, Mahapatra M, Seth T, Saxena R. Spectrum of hemostatic disorders in Indian females presenting with bleeding manifestations. Int J Lab Hematol 2018; 40:437-441. [PMID: 29575615 DOI: 10.1111/ijlh.12806] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2017] [Accepted: 02/16/2018] [Indexed: 11/27/2022]
Abstract
INTRODUCTION Hemostatic disorders are often missed in women with bleeding particularly menorrhagia. Preexisting hemostatic disorders are now known as common risk factor for postpartum hemorrhage and prolonged bleeding in puerperium. Females with bleeding complaints constitute an important population referred to hematology clinic. Hence, we aim to evaluate the type and frequency of hemostatic disorders among females presenting with bleeding in a tertiary care hospital and a basic hemostatic laboratory. METHODS Three-year data were retrospectively analyzed for 200 females with various bleeding complaints. Due to resource constraints, a hemostatic workup was done with prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen assay, clot solubility test, mixing studies, specific factor assays, platelet function test, and von Willebrand factor antigen level. RESULTS A total of 200 females were investigated to identify the cause of their bleeding. Thirty-five of 200 (17.5%) females were found with an underlying bleeding disorder. Of these 35 females, 65.7% presented with bleeding from more than 1 site. Most common bleeding manifestation was spontaneous bruising in 18 of 35 (51.4%) patients followed by petechiae (48.6%). Inherited bleeding disorders were noted in majority. The most common inherited bleeding disorder identified was von Willebrand disease (VWD) in 34.3% females. Second most common disorder was Glanzmann's thrombasthenia accounting for 22.8%. Rare coagulation factor deficiency, such as factors VII, X, and XIII deficiencies, was noted. Three cases revealed acquired causes of coagulation defects. CONCLUSION Underlying hemostatic defects should be searched for in women with unexplained bleeding complaints. This will not only help in diagnosis but also in proper management for future hemostatic challenges.
Collapse
Affiliation(s)
- A Gupta
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| | - P Mishra
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| | - H P Pati
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| | - S Tyagi
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| | - M Mahapatra
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| | - T Seth
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| | - R Saxena
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| |
Collapse
|
9
|
Chhikara S, Sazawal S, Seth T, Chaubey R, Singh K, Sharma R, Mishra P, Mahapatra M, Saxena R. Molecular Response to Imatinib and Its Correlation with mRNA Expression Levels of Imatinib Influx Transporter (OCT1) in Indian Chronic Myeloid Leukemia Patients. Asian Pac J Cancer Prev 2017; 18:2043-2048. [PMID: 28843219 PMCID: PMC5697457 DOI: 10.22034/apjcp.2017.18.8.2043] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
Background and objectives: Imatinib mesylate is approved for the treatment of Chronic Myeloid Leukemia (CML). About 20% of patients with CML do not respond to treatment with Imatinib either initially or because of acquired resistance. In addition to mutated BCR-ABL1 kinase, the organic cation transporter1 (OCT1, encoded by SLC22A1) has been considered to contribute to Imatinib resistance in patients with chronic myeloid leukemia (CML). OCT1 has been reported to be the main influx transporter involved in Imatinib uptake into CML cells. To date, only a few studies have been reported on involvement of influx transporters in development of Imatinib resistance. Therefore this study was aimed to determine the expression level of Imatinib uptake transporter (OCT1) in CML patients and to correlate this level with molecular response. Methods: One hundred fifty eight patients on Imatinib were considered for gene expression analysis study for OCT1 gene. Total RNA was extracted from peripheral blood mononuclear cells. Complementary DNAs (cDNAs) were synthesized and Real Time Polymerase Chain Reaction (RQ-PCR) was performed. Results: High OCT1 expression was present in 81 (51.8%) patients and low OCT1 expression was in 77 (48.7%) patients. Low Sokal risk score group have a significantly high OCT1 expression (p=0.048). The rate of molecular response was higher in those with high OCT1 expression than in those with low OCT1 expression (p=0.05). Both event-free survival and median overall survival were significantly shorter in patients with low OCT1 expressions when compared to the patients with high OCT1 expression (p=0.03 and p=0.05). Conclusions: Our findings demonstrated that the mRNA expression level of OCT1 was significantly correlated with molecular response in CML patients. Based on these findings, present study believes that the pre-therapeutic higher expression of OCT1 may help to predict response to imatinib therapy in CML patients.
Collapse
Affiliation(s)
- S Chhikara
- Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Kotru M, Munjal SS, Singh M, Seth T, Pati HP. Blood Components Load in Post-operative Neurosurgical Patients Suspected with Disseminated Intravascular Coagulation. Indian J Hematol Blood Transfus 2017; 33:408-411. [PMID: 28824246 DOI: 10.1007/s12288-016-0771-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2016] [Accepted: 12/19/2016] [Indexed: 10/20/2022] Open
Abstract
Neurosurgical patients with suspected DIC receive large amount of transfusion support in form of red cell concentrates (RCC), platelet rich plasma (PRP) and fresh frozen plasma (FFP). However, there are very few studies which have studied the effect of blood components load in the outcome of the patient. We conducted a prospective observational study on 61 post operative neurosurgery patients suspected with DIC and had at least one deranged haemostatic parameter namely platelet count, prothrombin time, partial thromboplastin time and thrombin time. Their blood components load was co-related with the outcome and with the hemostatic derangements. Twenty-eight patients died in our study group. 19/28 died patients had DIC. The red cell load was significantly more in patients who died compared to those who were alive (p = 0.041). On the other hand, load of PRP as well as FFP was significantly different between the patients who were alive and dead. This difference was further heightened when the DIC deaths were compared with the other patients. This is especially true for FFP transfusion which was significantly higher in DIC deaths (p = 0.006). Also, the number of FFPs received by neurosurgical patients suspected with DIC was significantly more in patients >2 coagulation abnormalities (p = 0.008). However, no correlation was found between PRP and RCC received and number of coagulation abnormalities present. To conclude, the load of FFP was maximum in patients with DIC deaths and the load of RCC was associated with overall mortality.
Collapse
Affiliation(s)
- M Kotru
- Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029 India
| | - S S Munjal
- Department of Neurosurgery, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029 India
| | - M Singh
- Department of Neurosurgery, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029 India
| | - T Seth
- Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029 India
| | - H P Pati
- Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029 India
| |
Collapse
|
11
|
Rai AK, Singh A, Saxena A, Seth T, Raina V, Mitra DK. Exonal switch down-regulates the expression of CD5 on blasts of acute T cell leukaemia. Clin Exp Immunol 2017; 190:340-350. [PMID: 28752543 DOI: 10.1111/cei.13019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/23/2017] [Indexed: 11/27/2022] Open
Abstract
To date, CD5 expression and its role in acute T cell lymphoblastic leukaemia (T-ALL) have not been studied closely. We observed a significant reduction in surface expression of CD5 (sCD5) on leukaemic T cells compared to autologous non-leukaemic T cells. In this study, we have shown the molecular mechanism regulating the expression and function of CD5 on leukaemic T cells. A total of 250 patients suffering from leukaemia and lymphoma were immunophenotyped. Final diagnosis was based on their clinical presentation, morphological data and flow cytometry-based immunophenotyping. Thirty-nine patients were found to be of ALL-T origin. Amplification of early region of E1A and E1B transcripts of CD5 was correlated with the levels of surface and intracellular expression of CD5 protein. Functional studies were performed to show the effect of CD5 blocking on interleukin IL-2 production and survival of leukaemic and non-leukaemic cells. Lack of expression of sCD5 on T-ALL blasts was correlated closely with predominant transcription of exon E1B and significant loss of exon E1A of the CD5 gene, which is associated with surface expression of CD5 on lymphocytes. High expression of E1B also correlates with increased expression of cytoplasmic CD5 (cCD5) among leukaemic T cells. Interestingly, we observed a significant increase in the production of IL-2 by non-leukaemic T cells upon CD5 blocking, leading possibly to their increased survival at 48 h. Our study provides understanding of the regulation of CD5 expression on leukaemic T cells, and may help in understanding the molecular mechanism of CD5 down-regulation.
Collapse
Affiliation(s)
- A K Rai
- Cellular Immunology Division, Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences (AIIMS), New Delhi, India.,Department of Biotechnology, Motilal Nehru National Institute of Technology Allahabad, Allahabad, India
| | - A Singh
- Cellular Immunology Division, Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences (AIIMS), New Delhi, India
| | - A Saxena
- Cellular Immunology Division, Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences (AIIMS), New Delhi, India
| | - T Seth
- Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, India
| | - V Raina
- Department of Medical Oncology, BRAIRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India
| | - D K Mitra
- Cellular Immunology Division, Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences (AIIMS), New Delhi, India
| |
Collapse
|
12
|
Dass J, Dayama A, Mishra PC, Mahapatra M, Seth T, Tyagi S, Pati HP, Saxena R. Higher rate of central nervous system involvement by flow cytometry than morphology in acute lymphoblastic leukemia. Int J Lab Hematol 2017. [PMID: 28649769 DOI: 10.1111/ijlh.12694] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
INTRODUCTION Central nervous system (CNS) involvement in acute lymphoblastic leukemia (ALL) is diagnosed traditionally by cytopathology (CP) of the cerebrospinal fluid (CSF). Role of flow cytometry (FC) to diagnose CNS involvement has not been extensively investigated. METHODS We aimed to detect CNS involvement in 42 ALL patients (33 B-ALL, nine T-ALL) at diagnosis by FC and comparing it with CP and to correlate it with known risk factors for CNS disease like Lactate dehydrogenase (LDH). A receiver operating characteristic curve was used to determine the cutoff of LDH to predict CSF involvement. For the analysis of categorical/quantitative variables, Fisher's exact test was used. For the analysis of continuous variables, Mann-Whitney test was used. A P value of <.05 was taken as significant. RESULTS CP and FC were positive in five (11.9%) and 11 patients (26.14%) respectively with FC detecting a significantly higher level of involvement (P=.001). All CP-positive cases were FC positive. A LDH value of >472 U/L had a sensitivity of 61% and specificity of 62.5% for diagnosis of CSF involvement by FC. CONCLUSIONS CSF FC detects CNS disease in ALL patients at diagnosis at a rate double than CP alone and is statistically associated with an elevated LDH level. It should be incorporated in the evaluation of CSF to detect CNS involvement.
Collapse
Affiliation(s)
- J Dass
- Department of Hematology, Sir Ganga Ram Hospital, New Delhi, India
| | - A Dayama
- Department of Hematology, Fortis Memorial Research Institute, Gurgaon, India
| | - P C Mishra
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| | - M Mahapatra
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| | - T Seth
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| | - S Tyagi
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| | - H P Pati
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| | - R Saxena
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
| |
Collapse
|
13
|
Mahapatra M, Singh PK, Agarwal M, Prabhu M, Mishra P, Seth T, Tyagi S, Patil HP, Saxena R. Epidemiology, Clinico-Haematological Profile and Management of Aplastic Anaemia: AIIMS Experience. J Assoc Physicians India 2015; 63:30-35. [PMID: 26529865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
BACKGROUND The incidence of aplastic anaemia (AA) is higher in Asia than in the West. The precise incidence of AA in India is not known due to lack of epidemiological study. 20-40% of pancytopenic patients in referral centres are of aplastic anaemia. PATIENTS AND METHODS This was an analysis of 1501 patients diagnosed with aplastic anaemia over a period of seven and half years (January 2007- June 2014) attending the Aplastic clinic of department of haematology of All India Institute of Medical Sciences, New Delhi. The details regarding medical history, physical examination, complete blood count, bone marrow aspirate and biopsy, treatment received, were retrieved. Inherited bone marrow failure was screened in patients below 35 years. Treatment response was analysed for various treatment modalities. RESULTS 1501 patients of AA from 20 different states of India were analysed. The bulk of patients were from Uttar Pradesh (28.7%), Bihar (23.6%), Delhi/NCR (20%) and Haryana (7%).The average number of new aplastic anaemia patients enrolled per year 214 (range: 101 -263). The median age at presentation was 25 years (range 2-83),with M;F - 2.3:1. Severity of AA revealed: severe (SAA): 75%, very severe (VSAA): 15%, non-severe (NSAA): 10%. Inherited bone marrow failure syndromes constituted 5% (75 patients) of all aplastic anaemia patients. The most common clinical presentations were pallor (97%), bleeding manifestations (69.6%) and fever (54%). The haematological parameters showed: median level of haemoglobin level: 5.9 gm/dL, WBC: 2700/mm3, ANC: 380/mm3, platelet: 1 0000/mm3. PNH clone was present in 13.5% of patients. 107 patients (7%) were lost to follow up or expired before any treatment was initiated. Only 69 patients (4.5%) received treatment with HLA-matched sibling stem cell transplantation and another 232 (15.5%) patients received ATG plus cyclosporine as immunosuppressive therapy. Seven hundred thirteenpatients (47.5%) received cyclosporine. The overall response to various treatment modalities was: HLA matched sibling haematopoietic stem cell transplant: 75.3%, Anti-thymocyte globulin plus cyclosporine: 58.7%, cyclosporine plus androgen: 45.6%, cyclosporine alone: 32.2%. CONCLUSION Management of AA is a real challenge in developing countries.This is one of the largest case series from a single centre from India. It is our endeavour to reduce the detrimental outcome by increasing awareness among patients and referring physicians to reduce the delay between diagnosis and treatment.
Collapse
|
14
|
Dass J, Dayama A, Seth T, Mahapatra M, Mishra PC, Saxena R. Clinico-hematological profile and outcome of acute promyelocytic leukemia patients at a tertiary care center in North India. Indian J Cancer 2015; 52:309-12. [DOI: 10.4103/0019-509x.176731] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
15
|
Singh N, Mohanty S, Seth T, Shankar M, Vanamail P, Saxena S. Role of subendometrial autologous stem cell implantation in women with asherman's syndrome. Fertil Steril 2013. [DOI: 10.1016/j.fertnstert.2013.07.715] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
16
|
Pandey S, Mishra RM, Suhail A, Rahul S, Ravi K, Pandey S, Seth T, Saxena R. Association of Low Serum Iron with Alpha Globin Gene Deletions and High Level of HbF with Xmn-1 Polymorphism in Sickle Cell Traits. Indian J Clin Biochem 2012; 27:270-3. [PMID: 26405386 PMCID: PMC4577506 DOI: 10.1007/s12291-011-0170-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2011] [Accepted: 09/24/2011] [Indexed: 11/30/2022]
Abstract
Usually sickle cell traits are asymptomatic but co-existence of various factrors may alter the clinical as well as biochemical levels. In India sickle cell traits are neglected condition. Here we are presenting the alpha deletion in association with low serum iron and increased HbF level with Xmn-1 carriers in sickle cell traits. Sickle traits with alpha deletions had significantly low level of serum iron (P-value <0.05) with low level of reticulocytes and red cell indices while Xmn-1 polymorphism associated with increased HbF level. Study concludes low serum iron associated with alpha deletions and high level of HbF associated with Xmn-1 polymorphism in sickle cell traits.
Collapse
Affiliation(s)
- S. Pandey
- />Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110 029 India
| | - R. M. Mishra
- />Department of Environmental Biology, APS University Rewa, Rewa, India
| | - A. Suhail
- />Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110 029 India
| | - S. Rahul
- />Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110 029 India
| | - K. Ravi
- />Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110 029 India
| | - Sw. Pandey
- />Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110 029 India
| | - T. Seth
- />Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110 029 India
| | - R. Saxena
- />Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110 029 India
| |
Collapse
|
17
|
Seth T, Kanga U, Sood P, Sharma V, Mishra P, Mahapatra M. Audit of Peripheral Stem Cell Transplantation for Aplastic Anemia in Multitransfused Infected Patients. Transplant Proc 2012; 44:922-4. [DOI: 10.1016/j.transproceed.2012.01.101] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
18
|
Sazawal S, Rathi S, Chikkara S, Chaubey R, Seth T, Saraya A, Das J, Mahapatra M, Saxena R. JAK2 mutation in patients with splanchnic venous thrombosis: a pilot study from India. Indian J Med Res 2012; 135:429-31. [PMID: 22561633 PMCID: PMC3361883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Affiliation(s)
- S. Sazawal
- Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India
| | - S. Rathi
- Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India
| | - S. Chikkara
- Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India
| | - R. Chaubey
- Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India
| | - T. Seth
- Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India
| | - A. Saraya
- Department of Gastroenterology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India
| | - J. Das
- Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India
| | - M. Mahapatra
- Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India
| | - R. Saxena
- Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India,For correspondence: Dr Renu Saxena, Department of Hematology, IRCH Building (1st Floor), All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India
| |
Collapse
|
19
|
Abstract
Lipid antigens of Leishmania donovani like lipophosphoglycans are shown as a potent ligand for the activation of invariant natural killer T (iNKT) cells. It is reported that activation of iNKT cells augments the disease pathology in experimental visceral leishmaniasis (VL). In this study, we demonstrate the enrichment of iNKT cells in the bone marrow, one of the disease sites among patients with VL.
Collapse
Affiliation(s)
- A K Rai
- Department of Transplant Immunology and Immunogenetics, All India Institutes of Medical Sciences, Ansari Nagar, New Delhi, India
| | | | | | | |
Collapse
|
20
|
Budrukkar A, Sarin R, Jalali R, Munshi A, Badwe R, Seth T, Parmar V, Deshpande D. 5125 POSTER Five Year Clinical Outcome in 109 Women With Clinically Palpable Tumours (1-3 cm) Treated With Accelerated Partial Breast Irradiation Using Interstitial Brachytherapy. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)71567-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
21
|
Gazula S, Pawar DK, Seth T, Bal CS, Bhatnagar V. Extrahepatic portal venous obstruction: The effects of early ligation of splenic artery during splenectomy. J Indian Assoc Pediatr Surg 2011; 14:194-9. [PMID: 20419019 PMCID: PMC2858880 DOI: 10.4103/0971-9261.59600] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Aim: To objectively demonstrate the gain in blood volume and blood components following early ligation of splenic artery during splenectomy and splenorenal shunts in children with extra hepatic portal venous obstruction (EHPVO). Methods: Twenty-eight children (20 males and 8 females, mean age: 9.9 (±3.2) years) with EHPVO and hypersplenism were recruited. We followed a protocol of systematically locating and ligating the splenic artery first, followed by a 30-minute waiting period to allow the massive spleen to decongest via the splenic vein and venous collaterals and then completing the splenectomy by standard procedure. No intravenous fluid was administered during this 30-minute period. Blood samples were drawn just prior to splenic artery ligation and soon after splenectomy for the estimation of hematological and biochemical parameters. Results: We noticed a highly significant increase in the hemoglobin, hematocrit, leukocyte, platelet, and RBC counts by early ligation of the splenic artery (p < 0.0004). The gain in hemoglobin and hematocrit was equivalent to a transfusion of atleast 100-150 ml of packed RBC. The increase in platelet count was equivalent to a platelet transfusion of atleast 4 units of platelet concentrates in an adult. There is a positive correlation between the splenic weight and the platelet gain (p= 0.0568) and the splenic volume on preoperative imaging and the platelet gain (p= 0.0251). Conclusion: Early ligation of the splenic artery during splenectomy results in passive splenic decongestion and thereby a significant gain in blood components. This protocol appears to be a feasible blood conservation method to avoid blood transfusions in this group of hypersplenic EHPVO patients.
Collapse
Affiliation(s)
- Suhasini Gazula
- Department of Pediatric Surgery, All India Institute of Medical Sciences, New Delhi, India
| | | | | | | | | |
Collapse
|
22
|
Dolai TK, Bhargava R, Mahapatra M, Mishra P, Seth T, Pati H, Saxena R. Is imatinib safe during pregnancy? Leuk Res 2009; 33:572-3. [DOI: 10.1016/j.leukres.2008.08.002] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2008] [Revised: 08/01/2008] [Accepted: 08/02/2008] [Indexed: 11/29/2022]
|
23
|
Dolai TK, Kumar R, Bhargava R, Mahapatra M, Mishra P, Seth T, Kar R, Rathi S, Pati HP, Saxena R, Tyagi S. Multi-organ failure due to Mycobacterium tuberculosis and Aspergillus flavus infection after allogeneic bone marrow transplantation. Indian J Hematol Blood Transfus 2008; 24:78-80. [PMID: 23100951 DOI: 10.1007/s12288-008-0035-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2008] [Accepted: 08/05/2008] [Indexed: 11/29/2022] Open
Abstract
Mycobacterium tuberculosis (MT) is a serious, but rare infectious complication after allogeneic bone marrow transplantation (BMT). We describe a case of fatal sepsis due to MT and Aspergillus flavus after allogeneic BMT for Aplastic Anemia. The diagnosis was made on bone marrow biopsy and asitic fluid culture. Broadspectrum antituberculous and Amphotericin B therapy was started immediately after diagnosis. The patient developed severe hypoxia and finally died of multi-organ failure. Rapid progression of mycobacterial infection as well as fungal infection should be considered in patients post BMT with unexplained fever, particularly in patients from endemic areas.
Collapse
Affiliation(s)
- Tuphan Kanti Dolai
- Department of Hematology, IRCH Building, All India Institute of Medical Sciences (AIIMS), New Delhi, India
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Kurkure PA, Parikh PM, Narula G, Bhagwat R, Arora B, Banavali SD, Pai SK, Nair CN, Seth T, Laskar S, Muckaden MA. Clinico-biologic profile of Langerhans cell histiocytosis: A single institutional study. Indian J Cancer 2007; 44:93-8. [DOI: 10.4103/0019-509x.38939] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
25
|
Dominic JF, Kumar L, Kochupillai V, Raina V, Sharma A, Bakshi S, Seth T, Kapil A. A randomized prospective open labeled study of oral amoxicillin-clavulanate with intravenous ceftriaxone and amikacin in low risk febrile neutropenia. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.18551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
18551 Background: Empiric oral antibiotic administration is a treatment option in low risk febrile neutropenia. Methods: Low risk febrile neutropenia patients (expected neutropenic duration <7 days with no comorbid features) between 15 and 75 years of age were randomized to receive either oral amoxicillin-clavulanate 625 mg twice daily and levofloxacin 500 mg once daily or intravenous (i.v.) ceftriaxone 2 g and amikacin 15 mg/kg once daily. Most patients were treated on out patient basis. The primary end point was response to therapy- defervescence of fever within 72 hours with improvement in any clinical manifestation of infection and no recurrence of fever for 48 hours without use of antipyretics. Use of growth factors was not permitted except in treatment failure. The study was cleared by the institute ethics committee. Results: Sixty four episodes in 53 patients were evaluable, 33 in the i.v. group and 31 in the oral antibiotics group. The underlying diagnosis was bone and soft tissue sarcomas in 32 episodes, hematological cancers in 22 and other solid cancers in 10. The groups were equally matched for age (median 25 years in the i.v. arm and 19 years in the oral arm), gender, type of cancer, baseline absolute neutrophil count (median 200/μL in both arms) and duration of neutropenia (5 days and 4 days in the i.v. and oral groups respectively). A focus of infection was identified clinically in 15% of episodes and microbiologically in 11% of episodes; 57% of which were gram positive organisms and the rest gram negative. Seventy two percent (95% confidence interval 58% to 88%) in the i.v. arm and 77% (95% confidence interval 63% to 92%) in the oral arm responded to therapy. The only serious toxicity was one episode of convulsions in the i.v. group. All treatment failures received second line i.v. antibiotics. There was no mortality in either group. Comparing the two groups for equivalence (assuming a 25% difference between the two arms as unequal) the two groups were found to be equivalent with a power of 59% (p = 0.03). Conclusion: Oral antibiotics have comparable efficacy as intravenous antibiotics in the management of low risk febrile neutropenia. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- J. F. Dominic
- All India Institute of Medical Sciences, New Delhi, India
| | - L. Kumar
- All India Institute of Medical Sciences, New Delhi, India
| | - V. Kochupillai
- All India Institute of Medical Sciences, New Delhi, India
| | - V. Raina
- All India Institute of Medical Sciences, New Delhi, India
| | - A. Sharma
- All India Institute of Medical Sciences, New Delhi, India
| | - S. Bakshi
- All India Institute of Medical Sciences, New Delhi, India
| | - T. Seth
- All India Institute of Medical Sciences, New Delhi, India
| | - A. Kapil
- All India Institute of Medical Sciences, New Delhi, India
| |
Collapse
|
26
|
Kumar R, Prem S, Mahapatra M, Seth T, Chowdhary DR, Mishra P, Pillai L, Narendra AMVR, Mehra NK, Saxena R, Choudhry VP. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia. Bone Marrow Transplant 2006; 37:745-9. [PMID: 16518427 DOI: 10.1038/sj.bmt.1705321] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Multiply transfused patients of severe aplastic anemia are at increased risk of graft rejection. Five such patients underwent peripheral blood stem cell transplantation from HLA-identical siblings with a fludarabine-based protocol. The conditioning consisted of fludarabine 30 mg/m(2)/day x 6 days, cyclophosphamide 60 mg/kg/day x 2 days and horse antithymocyte globulin (ATG) x 4 days. Two different ATG preparations were used: ATGAM (dose 30 mg/kg/day x 4 days) or Thymogam (dose 40 mg/kg/day x 4 days). Engraftment: median time to absolute neutrophil count (ANC) >0.5 x 10(9)/l was 11 days (range: 8-17) and median time to platelet count >20 x 10(9)/l was 11 days (range: 9-17). At a median follow-up of 171 days (range: 47-389), there has been no graft rejection and all patients are in complete remission. Acute GVHD (grade 1) occurred in one patient only. Chronic GVHD developed in two patients (extensive in one and limited in another). The transplants were performed in non-HEPA filter rooms. In only one patient, systemic antifungal therapy (voriconazole) was used. The use of Thymogam brand of ATG for conditioning is being reported for the first time. Our experience suggests that this fludarabine-based protocol allows rapid sustained engraftment in high-risk patients without significant immediate toxicity.
Collapse
Affiliation(s)
- R Kumar
- Department of Hematology, All India Institute of Medical Sciences, New Delhi, India.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Kotwal A, Thakur R, Seth T. Correlates of tobacco-use pattern amongst adolescents in two schools of New Delhi, India. Indian J Med Sci 2005; 59:243-52. [PMID: 15988094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
BACKGROUND As adolescent tobacco use has been found to be a major predictor of future use, preventive efforts need to be focused on this section of population. OBJECTIVES To assess the role of knowledge regarding tobacco, risk-taking attitude, peers, and other influencers on tobacco and areca nut use, amongst adolescents. SETTINGS AND DESIGN A school-based cross-sectional study covering two schools. Students of classes IX and XI, of selected schools, participated in the study (n = 596). METHODS A pretested and validated, close ended, self-administered questionnaire was used. Sociodemographic factors, awareness regarding tobacco, risk-taking attitudes, role of peers and other influencers, and tobacco, areca nut and alcohol use, were studied. STATISTICAL ANALYSIS Point estimates, 98% Confidence Intervals, tests of significance, bivariate and multivariate analysis (multiple logistic regression). RESULTS Almost 42% of tobacco users started before the age of 12 years. Peer pressure, general stress, and media were important influencers. Logistic regression analysis showed that students in public school were using more tobacco [Odds ratio (OR) = 1.85, P = 0.174] and tobacco/areca nut (OR = 1.14, P = 0.02). The difference in use between the genders and class in which studying was statistically not significant. Lesser proportion of those possessing adequate knowledge regarding tobacco used it as compared to those without adequate knowledge (OR = 0.13, P < 0.001) however, possession of adequate knowledge was not a good predictor of areca nut consumption (OR = 0.86, P = 0.585). The most important correlate for tobacco use (OR = 6.41, P < 0.001) and areca nut use (OR = 11.17, P < 0.001) was risk-taking attitude. CONCLUSION Multi-pronged and concerted efforts targeting children at an early age are required to prevent tobacco and areca nut use among adolescents.
Collapse
Affiliation(s)
- A Kotwal
- Management Information Systems Organization, Army Headquarters, New Delhi, India
| | | | | |
Collapse
|
28
|
Seth T, Kotwal A, Thakur R, Singh P, Kochupillai V. Common cancers in India: knowledge, attitudes and behaviours of urban slum dwellers in New Delhi. Public Health 2005; 119:87-96. [PMID: 15694955 DOI: 10.1016/j.puhe.2004.05.013] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2003] [Revised: 04/02/2004] [Accepted: 05/08/2004] [Indexed: 11/29/2022]
Abstract
RESEARCH QUESTIONS What is the level of knowledge and awareness of common cancers? What are the prevalent attitudes and behaviours relating to common cancers? OBJECTIVES To assess knowledge, attitudes and behaviours regarding common cancers amongst urban slum dwellers in New Delhi. STUDY DESIGN Field-based cross-sectional survey of an urban slum cluster. SETTING Slum clusters along Pankha Road, West New Delhi. PARTICIPANTS Slum dwellers of selected slums. STUDY VARIABLES Independent variables were sociodemographic factors. Dependent variables were knowledge, attitudes and behaviours regarding preventive and curative aspects of common cancers. STATISTICAL ANALYSIS Proportions, confidence intervals, tests of significance and multiple logistic regression. RESULTS Only 13% (10.6-15.7%) of the study participants were aware of Pap smears, and only 2% (1.1-3.3%) were able to identify all the common signs of cancer. However, 87% (84.4-89.5%) of the study participants knew that tobacco is a risk factor for cancer. Overall, 51% (47.2-54.7%) had some knowledge pertaining to cancer. CONCLUSION A focused, concerted and effective information, education and communication drive is urgently needed for all aspects of common cancers in India.
Collapse
Affiliation(s)
- T Seth
- Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Room No 13, 2nd Floor, Ansari Nagar, New Delhi 110029, India.
| | | | | | | | | |
Collapse
|
29
|
|
30
|
Abstract
Extralobar pulmonary sequestration is a rare pulmonary parenchymal anomaly which rarely may be present in an intra-abdominal location. The authors report a case of intra-abdominal extralobar pulmonary sequestration which presented to us as an antenatally diagnosed suprarenal mass and was worked up as such. The diagnosis was revealed only at laparotomy. Intra-abdominal extralobar pulmonary sequestration should also be kept in differential diagnosis in cases of masses in the suprarenal location, especially on the left side.
Collapse
Affiliation(s)
- A K Singal
- Department of Pediatric Surgery, All India Institute of Medical Sciences, New Delhi, India
| | | | | | | | | |
Collapse
|
31
|
Kotwal A, Priya R, Thakur R, Gupta V, Kotwal J, Seth T. Injection practices in a metropolis of North India: perceptions, determinants and issues of safety. Indian J Med Sci 2004; 58:334-44. [PMID: 15345887] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/30/2023]
Abstract
BACKGROUND At least 50 percent of the injections administered each year are unsafe, more particularly in developing countries, posing serious health risks. An initial assessment to describe injection practices; their determinants and adverse effects can prevent injection-associated transmission of blood borne pathogens by reducing injection frequency and adoption of safe injection practices. AIMS To assess the injection practices in a large metropolitan city encompassing varied socio-cultural scenarios. STUDY SETTING AND DESIGN: Field based cross sectional survey covering urban non-slum, slum and peri-urban areas of a large metropolitan city. METHODS AND MATERIAL Injection prescribers, providers and community members selected by random sampling from the study areas. Pre tested questionnaires assessed knowledge and perceptions of study subjects towards injections and their possible complications. Observation of the process of injection and prescription audit also carried out. STATISTICAL ANALYSIS MS Access for database and SPSS ver 11 for analysis. Point estimates, 95% confidence intervals, Chi Square, t test, one-way ANOVA. RESULTS The per capita injection rate was 5.1 per year and ratio of therapeutic to immunization injections was 4.4:1. Only 22.5%of injections were administered with a sterile syringe and needle. The level of knowledge about HIV and HBV transmission by unsafe injections was satisfactory amongst prescribers and community, but inadequate amongst providers. HCV was known to a very few in all the groups. The annual incidence of needle stick injuries among providers was quite high. CONCLUSION A locally relevant safe injection policy based on multi disciplinary approach is required to reduce number of injections, unsafe injections and their attendant complications.
Collapse
Affiliation(s)
- A Kotwal
- Center of Social Medicine & Community Health, Jawaharlal Nehru University, New Delhi - 110 064, India.
| | | | | | | | | | | |
Collapse
|
32
|
Seth T, Kotwal A, Thakur R. Understanding factors which influence tobacco (smoking and smokeless) in secondary school children in Delhi (India). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.1024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- T. Seth
- Institute Rotary Cancer Hospital,AIIMS, New Delhi, India; Army Base Hospital, New Delhi, India
| | - A. Kotwal
- Institute Rotary Cancer Hospital,AIIMS, New Delhi, India; Army Base Hospital, New Delhi, India
| | - R. Thakur
- Institute Rotary Cancer Hospital,AIIMS, New Delhi, India; Army Base Hospital, New Delhi, India
| |
Collapse
|
33
|
Wadhwa J, Kichenadasse G, Chowdhary GS, Seth T, Raina V, Deo SVS, Shukla NK, Rath GK. Clinical characteristics and survival outcome in women with metastatic breast cancer. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- J. Wadhwa
- IRCH, All India Institute of Medical Sciences, New Delhi, India
| | - G. Kichenadasse
- IRCH, All India Institute of Medical Sciences, New Delhi, India
| | - G. S. Chowdhary
- IRCH, All India Institute of Medical Sciences, New Delhi, India
| | - T. Seth
- IRCH, All India Institute of Medical Sciences, New Delhi, India
| | - V. Raina
- IRCH, All India Institute of Medical Sciences, New Delhi, India
| | - S. V. S. Deo
- IRCH, All India Institute of Medical Sciences, New Delhi, India
| | - N. K. Shukla
- IRCH, All India Institute of Medical Sciences, New Delhi, India
| | - G. K. Rath
- IRCH, All India Institute of Medical Sciences, New Delhi, India
| |
Collapse
|
34
|
Arora B, Kumar L, Das BC, Kailash U, Soundararajan CC, Seth T, Kochupillai V. Telomerase activity and human telomerase reverse transcriptase mRNA expression in acute lymphoblastic leukemia. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.6705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- B. Arora
- AII India Institute of Medical Sciences, New Delhi, India; Institute of Cytology and Preventive Oncology, ICMR, New Delhi, India; Institute of Cytology and Preventive Oncology,ICMR, New Delhi, India
| | - L. Kumar
- AII India Institute of Medical Sciences, New Delhi, India; Institute of Cytology and Preventive Oncology, ICMR, New Delhi, India; Institute of Cytology and Preventive Oncology,ICMR, New Delhi, India
| | - B. C. Das
- AII India Institute of Medical Sciences, New Delhi, India; Institute of Cytology and Preventive Oncology, ICMR, New Delhi, India; Institute of Cytology and Preventive Oncology,ICMR, New Delhi, India
| | - U. Kailash
- AII India Institute of Medical Sciences, New Delhi, India; Institute of Cytology and Preventive Oncology, ICMR, New Delhi, India; Institute of Cytology and Preventive Oncology,ICMR, New Delhi, India
| | - C. C. Soundararajan
- AII India Institute of Medical Sciences, New Delhi, India; Institute of Cytology and Preventive Oncology, ICMR, New Delhi, India; Institute of Cytology and Preventive Oncology,ICMR, New Delhi, India
| | - T. Seth
- AII India Institute of Medical Sciences, New Delhi, India; Institute of Cytology and Preventive Oncology, ICMR, New Delhi, India; Institute of Cytology and Preventive Oncology,ICMR, New Delhi, India
| | - V. Kochupillai
- AII India Institute of Medical Sciences, New Delhi, India; Institute of Cytology and Preventive Oncology, ICMR, New Delhi, India; Institute of Cytology and Preventive Oncology,ICMR, New Delhi, India
| |
Collapse
|
35
|
Cairo MS, Agosti J, Ellis R, Laver JJ, Puppala B, deLemos R, Givner L, Nesin M, Wheeler JG, Seth T, van de Ven C, Fanaroff A. A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr 1999; 134:64-70. [PMID: 9880451 DOI: 10.1016/s0022-3476(99)70373-2] [Citation(s) in RCA: 58] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
OBJECTIVE We carried out a randomized placebo-controlled trial in very low birth weight neonates (VLBWNs), comparing the incidence of nosocomial infections after the prophylactic use of recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) versus placebo in VLBWNs. STUDY DESIGN VLBWNs (n = 264), weighing 501 to 1000 g, </=72 hours of age were randomly assigned to receive rhu GM-CSF (8 microg/kg/d), administered intravenously (n = 134) over 2 hours daily x 7 days and every other day for 21 days, or placebo (n = 130). The safety, incidence of nosocomial infections, days of absolute neutrophil count >/=4000/mm,3 peripheral blood progenitor studies, and 24-hour polymorphonuclear leukocyte C3bi receptor expression were compared between the 2 treatment groups. RESULTS No (grade III/IV) toxicity or adverse events were associated with rhu GM-CSF. The absolute neutrophil count and absolute eosinophil count were significantly elevated in the rhu GM-CSF group on days 7 (P =.001), 14 (P =.001), and 21 (P =.007) and on days 7 and 28 (P =.012 and P =.001, respectively). However, there was no difference in the incidence of confirmed nosocomial infections between the 2 treatment groups in this trial (40% vs 39%, rhu GM-CSF vs placebo; P = NS). CONCLUSION In a large randomized placebo-controlled trial, prophylactic administration of rhu GM-CSF in VLBWNs does not appear to decrease the incidence of nosocomial infections.
Collapse
Affiliation(s)
- M S Cairo
- Georgetown University and Lombardi Cancer Center, Washington, DC 20007, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|